A meeting is held to review the patents related to the implant. [Photo/WeChat ID: Shanghai_IPA]
A team led by Professor Wu Hao at Shanghai Jiao Tong University School of Medicine has secured market approval for China's first domestically developed auditory brainstem implant on Oct 20. Five core invention patents from the project were licensed to a company for clinical development.
To support medical innovation, Huangpu's IP administration has helped hospitals integrate patent analysis into clinical research and optimize their patent portfolios. It has also provided patent-related policy support for emerging fields such as brain-computer interfaces and digital healthcare.
The administration partners with the Shanghai Intellectual Property Exchange, science parks, and professional agencies to build a platform for biomedical technology transfer and licensing. It also organizes roadshows and competitions that connect hospitals, universities, and businesses.
Huangpu has further strengthened IP enforcement. Last year, the district held Shanghai's first district-level oral hearing in an administrative patent infringement case involving pharmaceutical procurement, with technical investigators' support.
The administration will continue to improve full-chain IP services, from patent development and commercialization to rights protection, helping more medical innovations reach the market.
